首页 | 本学科首页   官方微博 | 高级检索  
检索        

内脏脂肪素对巨噬细胞MMP-9的作用及其机制探讨
引用本文:范虞琪,何奔,王彬尧.内脏脂肪素对巨噬细胞MMP-9的作用及其机制探讨[J].上海交通大学学报(医学版),2009,29(9):1057.
作者姓名:范虞琪  何奔  王彬尧
作者单位:上海交通大学,医学院仁济医院心内科,上海,200001
摘    要:目的 研究内脏脂肪素(visfatin)对巨噬细胞基质金属蛋白酶-9(MMP-9)的作用及其机制。方法体外诱导THP-1单核细胞转化为巨噬细胞。为明确visfatin对MMP-9的作用,细胞分为两组:①巨噬细胞+visfatin 12 h组;②巨噬细胞+visfatin24 h组,两组的visfatin的质量浓度均为:0(对照组)、50、100、200、400 ng/mL。采用RT-PCR和Western blotting测定MMP-9基因和蛋白表达,明胶酶谱法检测MMP-9的活性。为明确visfatin对MMP-9的作用机制,细胞分为五组:①巨噬细胞未加刺激组(对照组);②巨噬细胞+ MAPK p38、ERK1/2、JNK信号通路抑制剂预处理1 h后加visfatin(200 ng/mL)24 h组;③巨噬细胞+过氧化物酶体增殖剂活化受体(PPARγ)天然及人工配体/ RXR配体预处理1 h后加visfatin(200 ng/mL)24 h组;④巨噬细胞+visfatin(200 ng/mL)24 h组(Vis200组);⑤巨噬细胞+visfatin(200 ng/mL)刺激不同时间组(5、10、15、30、60 min)。Western blotting检测MMP-9蛋白和PPARγ蛋白表达及visfatin刺激下巨噬细胞p38、ERK1/2、JNK MAPK磷酸化水平。结果 Visfatin能促进MMP-9基因及蛋白表达(P<0.05,P<0.01),同时增强了MMP-9的活性(P<0.01)。p38 MAPK、ERK1/2 MAPK通路抑制剂及RXR配体抑制visfatin对MMP-9表达具有上调作用;visfatin能促进p38 MAPK和ERK1/2 MAPK的磷酸化,但不影响PPARγ蛋白的表达。结论 Visfatin增加了巨噬细胞炎症因子的表达,该作用与p38 MAPK和ERK1/2MAPK信号通路有关;RXR可能参与了该过程。

关 键 词:内脏脂肪素  基质金属蛋白酶  丝裂原活化蛋白激酶  视黄醛X受体  动脉粥样硬化

Effects and mechanism of visfatin on MMP-9 in macrophages
FAN Yu-qi,HE Ben,WANG Bin-yao.Effects and mechanism of visfatin on MMP-9 in macrophages[J].Journal of Shanghai Jiaotong University:Medical Science,2009,29(9):1057.
Authors:FAN Yu-qi  HE Ben  WANG Bin-yao
Institution:Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200001, China
Abstract:Objective To investigate the effects and mechanism of visfatin on matrix metalloproteinases-9 (MMP-9) expression and invasive activity in macrophages. Methods THP-1 monocytes were induced into macrophages. To investigate the effects of visfatin on MMP-9, cells were divided into 2 groups: ①macrophages+visfatin 12 h;②macrophages+visfatin 24 h. The concentrations of visfatin in each group were:0(control), 50, 100, 200, 400 ng/mL. MMP-9 mRNA and protein expression were analysed by RT-PCR and Western blotting, and MMP-9 invasive activity was assayed by gelatin zymography. To investigate the mechanism of visfatin on MMP-9, cells were divided into 5 groups: ①macrophages without stimulation (control); ②macrophages pretreated with MAPK p38, ERK1/2, JNK pathway inhibitor for 1 h, then stimulated with visfatin (200 ng/mL)for 24 h; ③macrophages pretreated with retinoid X receptors (RXR) nature ligand or peroxisome proliferators activated receptor γ (PPARγ) natural/synthetic ligand for 1 h,then stimulated with visfatin(200 ng/mL)for 24 h; ④macrophages stimulated with visfatin (200 ng/mL) for 24 h; ⑤macophages+visfatin (200 ng/mL)for different time(5, 10, 15, 30, 60 min). MMP-9 expression, PPARγ expression, and the effect of visfatin on MAPK phosphorylation were analysed by Western blotting. Results Visfatin not only significantly enhanced MMP-9 mRNA and protein expression in macrophages(P<0.05, P<0.01), but also up-regulated MMP-9 invasive activity(P<0.01). p38 MAPK inhibitor, ERK1/2 MAPK inhibitor and RXR ligand significantly blocked visfatin activity. Visfatin activated the phosphorylation of p38 MAPK and ERK1/2 MAPK, while had no effect on expression of PPARγ protein. Conclusion Visfatin enhances inflammatory factors expression and activity in macrophages which is related with ERK1/2 MAPK and p38 MAPK, and RXR may mediate visfatin activity.
Keywords:visfatin  matrix metalloproteinase  mitogen-activated protein kinase  retinoid X receptors  atherosclerosis
本文献已被 万方数据 等数据库收录!
点击此处可从《上海交通大学学报(医学版)》浏览原始摘要信息
点击此处可从《上海交通大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号